Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

CVS Corp (CVS)

CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Stock Index Futures Muted With U.S. Retail Sales Data in Focus

March S&P 500 E-Mini futures (ESH26) are up +0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.04% this morning, taking a breather after a recent rally as investors await a slew of U.S. economic data, with particular attention on the retail sales report, remarks from Federal Reserve officials, and a new round of corporate earnings reports. 

The 10-year T-note yield fell two basis points to 4.18%.

Fundamentals

See More
  • Market Capitalization, $K 96,096,000
  • Shares Outstanding, K 1,269,432
  • Annual Sales, $ 372,809 M
  • Annual Income, $ 4,614 M
  • EBIT $ 10,641 M
  • EBITDA $ 15,238 M
  • 60-Month Beta 0.50
  • Price/Sales 0.24
  • Price/Cash Flow 8.34
  • Price/Book 1.32

Options Overview Details

View History
  • Implied Volatility 28.15% (-0.11%)
  • Historical Volatility 50.86%
  • IV Percentile 22%
  • IV Rank 15.05%
  • IV High 56.83% on 04/07/25
  • IV Low 23.07% on 08/28/25
  • Expected Move (DTE 1) 1.76 (2.28%)
  • Put/Call Vol Ratio 0.81
  • Today's Volume 5,821
  • Volume Avg (30-Day) 29,528
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 409,921
  • Open Int (30-Day) 417,407
  • Expected Range 75.26 to 78.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.26
  • Number of Estimates 10
  • High Estimate 2.47
  • Low Estimate 2.12
  • Prior Year 2.25
  • Growth Rate Est. (year over year) +0.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.69 +8.95%
on 01/27/26
84.00 -8.31%
on 01/26/26
-3.28 (-4.08%)
since 01/09/26
3-Month
70.69 +8.95%
on 01/27/26
84.00 -8.31%
on 01/26/26
-2.85 (-3.57%)
since 11/11/25
52-Week
58.35 +32.00%
on 05/15/25
85.15 -9.55%
on 10/29/25
+22.02 (+40.04%)
since 02/11/25

Most Recent Stories

More News
CVS Q4 Deep Dive: Pharmacy Turnaround and Regulatory Shifts Shape Outlook

CVS Q4 Deep Dive: Pharmacy Turnaround and Regulatory Shifts Shape Outlook

CVS : 77.02 (+1.74%)
CVS Health (NYSE:CVS) Surprises With Q4 CY2025 Sales

CVS Health (NYSE:CVS) Surprises With Q4 CY2025 Sales

CVS : 77.02 (+1.74%)
CVS Health: Q4 Earnings Snapshot

CVS Health: Q4 Earnings Snapshot

CVS : 77.02 (+1.74%)
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

Fourth Quarter Highlights

CVS : 77.02 (+1.74%)
Stock Index Futures Muted With U.S. Retail Sales Data in Focus

March S&P 500 E-Mini futures (ESH26) are up +0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.04% this morning, taking a breather after a recent rally as investors await a slew of U.S. economic...

META : 668.69 (-0.30%)
APP : 456.81 (-3.41%)
CVS : 77.02 (+1.74%)
THULE.S.DX : 232.800 (-3.00%)
AVGO : 342.76 (+0.68%)
KO : 78.60 (+2.33%)
CRDO : 128.40 (-4.69%)
F : 13.85 (+2.06%)
UPWK : 14.50 (-4.64%)
ESH26 : 6,979.75 (+0.28%)
KER.FP : 280.200 (+0.18%)
BP-.LN : 464.350 (-1.78%)
Stocks Set for Muted Open as Bond Yields Climb, Key U.S. Economic Data Awaited

March S&P 500 E-Mini futures (ESH26) are down -0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.19% this morning, pointing to a muted open on Wall Street as rising Treasury yields curbed...

MSTR : 126.07 (-5.21%)
AMAT : 339.88 (+3.29%)
APP : 456.81 (-3.41%)
CVS : 77.02 (+1.74%)
ANET : 140.66 (-1.94%)
CSCO : 85.54 (-0.87%)
F : 13.85 (+2.06%)
HIMS : 16.69 (-3.19%)
SHOP : 118.71 (-6.70%)
NQH26 : 25,349.75 (+0.24%)
BILL : 47.02 (-7.09%)
ON : 71.18 (+5.64%)
CVS Health (CVS) Q4 Earnings: What To Expect

CVS Health (CVS) Q4 Earnings: What To Expect

CVS : 77.02 (+1.74%)
CVS Pharmacy Now Accepting TrumpRx Discount Cards

WOONSOCKET, R.I. , Feb. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its approximately 9,000 community pharmacies are accepting TrumpRx discount cards, which offer savings...

CVS : 77.02 (+1.74%)
Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey

Press Ganey's inaugural Health Plan of the Year award recognizes Aetna's sustained excellence across member experience, quality performance and provider collaboration.

CVS : 77.02 (+1.74%)
CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes - Supporting Affordable Options for Osteoporosis Care

WOONSOCKET, R.I. , Feb. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS)  today announced new steps to further help customers expand adoption of lower-cost biosimilar medications. Effective April...

CVS : 77.02 (+1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed...

See More

Key Turning Points

3rd Resistance Point 80.59
2nd Resistance Point 78.81
1st Resistance Point 77.91
Last Price 77.02
1st Support Level 75.23
2nd Support Level 73.45
3rd Support Level 72.55

See More

52-Week High 85.15
Last Price 77.02
Fibonacci 61.8% 74.91
Fibonacci 50% 71.75
Fibonacci 38.2% 68.59
52-Week Low 58.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar